Trials / Completed
CompletedNCT00586625
Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 861 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Accepted
Summary
Safety study for bepotastine besilate ophthalmic solution in normal volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bepreve | One drop, both eyes, twice a day |
| DRUG | Placebo | One drop, both eyes, twice a day |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-05-01
- First posted
- 2008-01-04
- Last updated
- 2013-02-15
- Results posted
- 2009-11-11
Source: ClinicalTrials.gov record NCT00586625. Inclusion in this directory is not an endorsement.